Medicine
Volume 36, Issue 6 , Pages 285-290, June 2008

Bacterial pneumonia

Michael R Loebinger MA MRCP is an MRC Clinical Training Fellow and Specialist Registrar in Respiratory and General Medicine at the Host Defence Unit, Royal Brompton Hospital, London, UK. Competing interests: none declared

Robert Wilson MD FRCP is an NHS Consultant at the Host Defence Unit, Royal Brompton Hospital, London, UK. Competing interests: none declared

Abstract 

Bacterial pneumonia remains one of the leading causes of morbidity and mortality. National and international guidelines addressing the management of pneumonia have been developed over the last several years, with the aim of improving the care and outcomes of pneumonia. This article addresses many of these management issues with reference to changes in management for particular patient groups. The importance of stratifying risk and immediate emergency department management is discussed. In addition, response to therapy and follow-up management is examined. This article discusses the evidence behind present practice and possible future directions for pneumonia management with the advent of new biomarkers.

Keywords: antibiotics, bacteria, community-acquired pneumonia, infection, pneumonia, vaccination

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1357-3039(08)00105-9

doi:10.1016/j.mpmed.2008.03.011

Medicine
Volume 36, Issue 6 , Pages 285-290, June 2008

Article Tools

* Image Usage & Resolution